Literature DB >> 12682902

Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells.

Lala R Chaudhary1, Keith A Hruska.   

Abstract

Although curcumin has been shown to inhibit prostate tumor growth in animal models, its mechanism of action is not clear. To better understand the anti-cancer effects of curcumin, we investigated the effects of curcumin on cell survival factor Akt in human prostate cancer cell lines, LNCaP, PC-3, and DU-145. Our results demonstrated differential activation of Akt. Akt was constitutively activated in LNCaP and PC-3 cells. Curcumin inhibited completely Akt activation in both LNCaP and PC-3 cells. The presence of 10% serum decreased the inhibitory effect of curcumin in PC-3 cells whereas complete inhibition was observed in 0.5% serum. Very little or no activation of Akt was observed in serum starved DU-145 cells (0.5% serum). The presence of 10% serum activated Akt in DU-145 cells and was not inhibited by curcumin. Results suggest that one of the mechanisms of curcumin inhibition of prostate cancer may be via inhibition of Akt. To our knowledge this is the first report on the curcumin inhibition of Akt activation in LNCaP and PC-3 but not in DU-145 cells. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682902     DOI: 10.1002/jcb.10495

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  24 in total

1.  Enhancement of phototoxicity of curcumin in human oral cancer cells using silica nanoparticles as delivery vehicle.

Authors:  Surya Prakash Singh; Mrinalini Sharma; Pradeep Kumar Gupta
Journal:  Lasers Med Sci       Date:  2013-06-27       Impact factor: 3.161

2.  Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication.

Authors:  Xiaoning Si; Yahong Wang; Jerry Wong; Jingchun Zhang; Bruce M McManus; Honglin Luo
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism.

Authors:  Siwang Yu; Guoxiang Shen; Tin Oo Khor; Jung-Hwan Kim; Ah-Ng Tony Kong
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

4.  Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.

Authors:  Jin Chen; Feng-Ling Wang; Wei-Dong Chen
Journal:  Mol Biol Rep       Date:  2014-03-07       Impact factor: 2.316

Review 5.  Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment.

Authors:  Brian C Jordan; Charlotta D Mock; Ramasamy Thilagavathi; Chelliah Selvam
Journal:  Life Sci       Date:  2016-03-24       Impact factor: 5.037

6.  Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells.

Authors:  Xiuzhen Han; Baoshan Xu; Christopher S Beevers; Yoshinobu Odaka; Long Chen; Lei Liu; Yan Luo; Hongyu Zhou; Wenxing Chen; Tao Shen; Shile Huang
Journal:  Carcinogenesis       Date:  2012-01-31       Impact factor: 4.944

Review 7.  Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.

Authors:  Wenge Li; Tin Oo Khor; Changjiang Xu; Guoxiang Shen; Woo-Sik Jeong; Siwang Yu; Ah-Ng Kong
Journal:  Biochem Pharmacol       Date:  2008-07-23       Impact factor: 5.858

Review 8.  [A critical assessment of phytotherapy for prostate cancer].

Authors:  F G E Perabo; E C von Löw; R Siener; J Ellinger; S C Müller; P J Bastian
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

9.  Cancer-linked targets modulated by curcumin.

Authors:  Noor Hasima; Bharat B Aggarwal
Journal:  Int J Biochem Mol Biol       Date:  2012-12-24

10.  New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells.

Authors:  Ling Cen; Brian Hutzen; Sarah Ball; Stephanie DeAngelis; Chun-Liang Chen; James R Fuchs; Chenglong Li; Pui-Kai Li; Jiayuh Lin
Journal:  BMC Cancer       Date:  2009-03-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.